Vaccine production in South Africa: how an industry in its infancy can be developed
By Jeffrey Dorfman, Associate Professor in Medical Virology, Stellenbosch University
Frank Kirstein, Honorary Research Associate / Lecturer; Division of Immunology, Faculty of Health Sciences, University of Cape Town
If South Africa is serious about being able to supply anti-pandemic vaccines in future, it needs to rethink the scale of financial, technical and strategic investment into vaccine production.
Read complete article
© The Conversation
- Wednesday, January 20, 2021